Users' Guides to the Medical Literature: V. How to Use an Article About Prognosis

JAMA: The Journal of the American Medical Association

Volumn 272, Issue 3, 1994, Pages 234-237

  Laupacis, Andreas ^a   Wells, George ^a   Richardson, W Scott ^a   Tugwell, Peter ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGED; ALZHEIMER DISEASE; CASE REPORT; COGNITIVE DEFECT; FEMALE; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; PATIENT EDUCATION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; TREATMENT PLANNING;

EID: 0028291009     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03520030076032     Document Type: Article

References (19)

1. Molloy DW, Alemayehu E, Roberts R. Reliability of a standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Am J Psychiatry. 1991;148:102-105.
2. Walsh JS, Welch G, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990;113:429-434.
3. Levine M, Walter S, Lee H, et al, for the Evidence-Based Medicine Working Group. Users' guides to the medical literature, IV: how to use an article about harm. JAMA. 1994;271:1615-1619.
4. Dawber TR, Kaunel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963;107:539-556.
5. Bennett JC, for the Board on Health Sciences Policy of the Institute of Medicine. Inclusion of women in clinical trials: policies for population subgroups. N Engl J Med. 1993;329:288-292.
6. Ellenberg JH, Nelson KB. Sample selection and the natural history of disease: studies of febrile seizures. JAMA. 1980;243:1337-1340.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC; 1994:139-143.
8. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 1992; 339:1-15.
9. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology. 1978;28:973-977.
10. Pincus T, Brooks RH, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Intern Med. 1994;120:26-34.
11. Berger CJ, Murabito JM, Evans JC, Anderson KM, Levy D. Prognosis after first myocardial infarction: comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study. JAMA. 1992;228:1545-1551.
12. Katz MH, Hauck WW. Proportional hazards (Cox) regression. J Gen Intern Med. 1993;8:702-711.
13. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
14. Dorey F, Amstutz H. The validity of survivorship analysis in total joint arthroplasty. J Bone Joint Surg Am. 1989;71:544-548.
15. Laupacis A, Albers G, Dunn M, Feinberg W. Antithrombotic therapy in atrial fibrillation. Chest. 1992;102:426S-433S.
16. Kopecky SL. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med. 1987;317:669-674.
17. Meador CK. The art and science of nondisease. N Engl J Med. 1965;272:92.
18. Stern Y, Mayeux R, Hauser WA, Bush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology. 1987;37:1649-1653.
19. Drachman DA, O'Donnell BF, Lew RA, Swearer JM. The prognosis in Alzheimer's disease: 'how far' rather than 'how fast' best predicts the course. Arch Neurol. 1990;47:851-856.